Sarcopenia, Obesity and Sarcopenia Obesity in Comparison: Prevalence, Metabolic Profile, and Key Differences: Results from WCHAT Study

被引:51
|
作者
Liu, X. [1 ,2 ]
Hao, Q. [1 ,2 ]
Yue, J. [1 ,2 ]
Hou, L. [1 ,2 ]
Xia, X. [1 ,2 ]
Zhao, W. [1 ,2 ]
Zhang, Y. [1 ,2 ]
Ge, M. [1 ,2 ]
Ge, N. [1 ,2 ]
Dong, B. [1 ,2 ]
机构
[1] Sichuan Univ, West China Hosp, Natl Clin Res Ctr Geriatr, 37 Guo Xue Xiang Rennin Nan Lu, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Dept Geriatr, 37 Guo Xue Xiang, Chengdu 610041, Sichuan, Peoples R China
来源
JOURNAL OF NUTRITION HEALTH & AGING | 2020年 / 24卷 / 04期
关键词
Sarcopenia; obesity; sarcopenia obesity; prevalence; West China; metabolic profile; VITAMIN-D; INSULIN-RESISTANCE; MUSCLE MASS; AGE; HEALTH; INFLAMMATION; ASSOCIATION; PROTEIN; ADULTS; INDEX;
D O I
10.1007/s12603-020-1332-5
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective To identify the prevalence, lifestyle factors, chronic disease status, and assessing the metabolic profile, comparing key differences in a cohort of subjects with non-sarcopenia/non-obesity (H), sarcopenia/non-obesity (S), non-sarcopenia/obesity (O) and sarcopenia obesity (SO) in a multi-ethnic population in west China. Design A cross-sectional study. Setting The communities in Yunnan, Guizhou, Sichuan, and Xinjiang provinces. Participants We included 4,500 participants aged 50 years or older who did bioelectrical impedance in our analysis from West China Health and Aging Trend (WCHAT) study. Measurements We measured gait speed, handgrip strength and muscle mass by using bioelectrical impedance analysis (BIA) for all participants. We defined sarcopenia using the diagnostic algorithm recommended by the Asian Working Group for Sarcopenia (AWGS). Obesity was defined as the highest sex-specific quintile of the percentage body fat. Different variables like anthropometry measures, life styles, chronic disease and blood test were collected. Analysis of variance and a multinomial logistic regression analysis adjusting for covariates were used to assess the differences of metabolic profiles among different groups. Results Of 4500 participants aged 50 years old or older, the proportions of H, O, S, SO were 63.0%, 17.7%, 16.7% and 2.6%, respectively. And the prevalence of S subjects in men was 18.3% and 15.7% in women, while the prevalence of SO was 3.7% in men and 2.0% in women. Data showed that the prevalence of S and SO has an aging increase pattern which was opposite with O. Both S and SO tends to be older, lower educational level, without spouse, smoking, comorbidity of chronic disease, poor nutrition status, depression and cognitive decline compared to H and S seems to be worse than SO. Compared to H, S cohort showed a decrease in Vitamin D, triglyceride, albumin, fasting glucose, insulin, creatinine, ALT, nutrition scores and increase in HDL. SO cohort were observed for an increase in cholesterol, LDL, total protein and decrease in vitamin D. While O cohort showed an increase in triglyceride, cholesterol, LDL, total protein, glucose, insulin, WBC, uric acid, ALT and nutrition scores, but a decrease in HDL and vitamin D level. Conclusions Among individuals aged 50 years old or older in West China. S, O and SO participants demonstrate distinct differences in the life-styles, chronic disease profile, and metabolic profiles. The prevalence of S and SO has an aging increase pattern contrary to O. Both S and SO tend to be older, lower educational level, without spouse, smoking, comorbidity of chronic disease, poor nutrition status, depression and cognitive decline compared to H and S looks like to be worse than SO. Besides, the S subjects seem to have more metabolic index changes than SO compared to H. While O subjects have some contrary metabolic index to S subjects.
引用
收藏
页码:429 / 437
页数:9
相关论文
共 50 条
  • [41] Sarcopenia prevalence and functional outcomes in older men with obesity: Comparing the use of the EWGSOP2 sarcopenia versus ESPEN-EASO sarcopenic obesity consensus definitions
    Scott, David
    Blyth, Fiona
    Naganathan, Vasi
    Couteur, David G. Le
    Handelsman, David J.
    Waite, Louise M.
    Hirani, Vasant
    CLINICAL NUTRITION, 2023, 42 (09) : 1610 - 1618
  • [42] Central obesity is associated with lower prevalence of sarcopenia in older women, but not in men: a cross-sectional study
    Seongmin Choi
    Jinmann Chon
    Seung Ah Lee
    Myung Chul Yoo
    Yeocheon Yun
    Sung Joon Chung
    Minjung Kim
    Eun Taek Lee
    Min Kyu Choi
    Chang Won Won
    Yunsoo Soh
    BMC Geriatrics, 22
  • [43] Prevalence and Determinant Factors of Sarcopenia in Patients With Type 2 Diabetes The Korean Sarcopenic Obesity Study (KSOS)
    Kim, Tae Nyun
    Park, Man Sik
    Yang, Sae Jeong
    Yoo, Hye Jin
    Kang, Hyun Joo
    Song, Wook
    Seo, Ji A.
    Kim, Sin Gon
    Kim, Nan Hee
    Baik, Sei Hyun
    Choi, Dong Seop
    Choi, Kyung Mook
    DIABETES CARE, 2010, 33 (07) : 1497 - 1499
  • [44] Nutritional status mediates the relationship between sarcopenia and cognitive impairment: findings from the WCHAT study
    Fengjuan Hu
    Hu Liu
    Xiaolei Liu
    Shuli Jia
    Wanyu Zhao
    Lixing Zhou
    Yunli Zhao
    Lisha Hou
    Xin Xia
    Birong Dong
    Aging Clinical and Experimental Research, 2021, 33 : 3215 - 3222
  • [45] Central obesity is associated with lower prevalence of sarcopenia in older women, but not in men: a cross-sectional study
    Choi, Seongmin
    Chon, Jinmann
    Lee, Seung Ah
    Yoo, Myung Chul
    Yun, Yeocheon
    Chung, Sung Joon
    Kim, Minjung
    Lee, Eun Taek
    Choi, Min Kyu
    Won, Chang Won
    Soh, Yunsoo
    BMC GERIATRICS, 2022, 22 (01)
  • [47] Nutritional status mediates the relationship between sarcopenia and cognitive impairment: findings from the WCHAT study
    Hu, Fengjuan
    Liu, Hu
    Liu, Xiaolei
    Jia, Shuli
    Zhao, Wanyu
    Zhou, Lixing
    Zhao, Yunli
    Hou, Lisha
    Xia, Xin
    Dong, Birong
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 33 (12) : 3215 - 3222
  • [48] Sarcopenia, obesity, and inflammation - results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study
    Cesari, M
    Kritchevsky, SB
    Baumgartner, RN
    Atkinson, HH
    Penninx, BWHJ
    Lenchik, L
    Palla, SL
    Ambrosius, WT
    Tracy, RP
    Pahor, M
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2005, 82 (02): : 428 - 434
  • [49] Sarcopenia and sarcopenic obesity after cholecystectomy: A population-based study
    Gan, Da
    Wang, Xiaoyan
    Xu, Xiaochen
    Kang, Qingcong
    Lu, Zhonghua
    Jia, Menghan
    Ru, Yuan
    He, Xi
    Mou, Yun
    He, Wei
    Zhu, Shankuan
    OBESITY, 2022, 30 (02) : 482 - 490
  • [50] Muscle mass adjustment method affects association of sarcopenia and sarcopenic obesity with metabolic syndrome
    Yilmaz, Ozlem
    Bahat, Gulistan
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2019, 19 (03) : 272 - 272